Database statistics
# of drugs
528
# of Most-DIQT concern
110
# of Moderate-DIQT concern
56
# of Ambiguous
262
# of No-DIQT concern
100
Drug-Induced QT Prolongation Atlas (DIQTA) contains information on U.S. FDA approved drugs and its potential to cause QT prolongation. A DIQT classification scheme defined in the database was developed based on drug labeling information. DIQTA mainly provides four folds of drug-induced QT prolongation related information including a classification scheme for drugs' potential to QT prolongation, post-marketing surveillance data of drug-induced QT prolongation, drug property information and the link to pharmacogenomics data.
Disclaimer:
The content of this database of QT prolongation is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.
Any mention of commercial products is for clarification and not intended as endorsement.